Similarly, in the TNBS-induced mouse colitis model, pre-treatment with IFN-γ demonstrated a better migration rate of MSCs to the site of injury, reduced damage of mucosal tissue from inflammation, and overall increased survival rates (72). This evidence concerns the gene IFNG and colitis.